Stryker Co. (SYK) is Wendell David Associates Inc.’s 3rd Largest Position
Wendell David Associates Inc. trimmed its holdings in Stryker Co. (NYSE:SYK) by 3.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 118,618 shares of the medical technology company’s stock after selling 3,781 shares during the quarter. Stryker comprises approximately 3.6% of Wendell David Associates Inc.’s portfolio, making the stock its 3rd biggest position. Wendell David Associates Inc.’s holdings in Stryker were worth $23,429,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in SYK. Campbell Capital Management Inc. acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $204,000. British Airways Pensions Investment Management Ltd boosted its holdings in shares of Stryker by 16.0% in the fourth quarter. British Airways Pensions Investment Management Ltd now owns 122,484 shares of the medical technology company’s stock valued at $19,214,000 after acquiring an additional 16,925 shares during the period. Landsberg Bennett & Dubbaneh LLC acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $1,926,000. Addenda Capital Inc. boosted its holdings in shares of Stryker by 14.9% in the first quarter. Addenda Capital Inc. now owns 23,593 shares of the medical technology company’s stock valued at $4,671,000 after acquiring an additional 3,060 shares during the period. Finally, Oakworth Capital Inc. boosted its holdings in shares of Stryker by 4.8% in the fourth quarter. Oakworth Capital Inc. now owns 6,840 shares of the medical technology company’s stock valued at $1,073,000 after acquiring an additional 314 shares during the period. 74.58% of the stock is owned by hedge funds and other institutional investors.
In other Stryker news, VP M Kathryn Fink sold 180 shares of the stock in a transaction on Monday, February 4th. The stock was sold at an average price of $176.77, for a total value of $31,818.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy J. Scannell sold 5,282 shares of the stock in a transaction on Wednesday, January 16th. The stock was sold at an average price of $163.50, for a total value of $863,607.00. The disclosure for this sale can be found here. Insiders sold 131,071 shares of company stock valued at $24,689,161 in the last quarter. 7.20% of the stock is currently owned by company insiders.
NYSE:SYK traded down $0.40 during trading hours on Thursday, hitting $195.74. The company’s stock had a trading volume of 386,242 shares, compared to its average volume of 1,041,552. The stock has a market capitalization of $72.90 billion, a price-to-earnings ratio of 26.78, a PEG ratio of 2.41 and a beta of 0.88. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.41 and a current ratio of 2.02. Stryker Co. has a 52-week low of $144.75 and a 52-week high of $199.85.
Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, January 29th. The medical technology company reported $2.18 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.15 by $0.03. The firm had revenue of $3.80 billion during the quarter, compared to analysts’ expectations of $3.73 billion. Stryker had a return on equity of 27.60% and a net margin of 26.12%. On average, analysts predict that Stryker Co. will post 8.13 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 1.06%. The ex-dividend date is Thursday, March 28th. Stryker’s payout ratio is 28.45%.
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Featured Story: Straddles
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.